טוען...
Immune checkpoint inhibitors as a real hope in advanced urothelial carcinoma
Metastatic urothelial cancer is an aggressive disease associated with a poor prognosis. In the first-line setting, platinum-based chemotherapy is the standard of care but resistance rapidly occurs. After failure of platinum-based therapy and in cisplatin-ineligible patients, therapeutic options are...
שמור ב:
| הוצא לאור ב: | Future Sci OA |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Future Science Ltd
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6234462/ https://ncbi.nlm.nih.gov/pubmed/30457576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fsoa-2018-0033 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|